Remove 2022 Remove Equities Remove Public Trading
article thumbnail

10-23-2023 Newsletter: Why Take-Private Dealmaking Remains Attractive for PE Investors

OfficeHours

Written by a top OfficeHours Coach; Original article published on October 16, 2023 In today’s world, there is much uncertainty around public markets. However, for private equity investors, this uncertainty represents a unique opportunity to take advantage of investment opportunities in public markets.

Investors 130
article thumbnail

08-20-2023 Newsletter: Sunday Reading

OfficeHours

Written by a Top OfficeHours Private Equity Coach Is PE a Good Fit for you? To know if the buyside is right for you, let’s start with a textbook understanding of “What is private equity?” During the hold period, the private equity firm can improve operations, management structure, and financial strategies to optimize the business.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Upgrade acquires travel-focused BNPL startup Uplift for a song

TechCrunch: M&A

Uplift had raised nearly $700 million in equity and debt, securing $123 million at a reported $195 million valuation in its Series C round alone. billion in July 2022 following an $800 million round. To blame could be general malaise in the BNPL sector post-pandemic, particularly among consumer-focused BNPL vendors. billion to just $6.7

Finance 225
article thumbnail

Why Take-Private Dealmaking Remains Attractive for PE Investors

OfficeHours

In today’s world, there is much uncertainty around public markets. However, for private equity investors, this uncertainty represents a unique opportunity to take advantage of investment opportunities in public markets. Another key reason is the potential ability to achieve higher returns than public investors.

Investors 100
article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in. Let’s dig in.

M&A 40
article thumbnail

SaaS M&A Snapshot: Target Market & Buyers

Software Equity Group

The public markets may have taken a beating, but behind the gloom-and-doom headlines, there was still plenty of good news for private SaaS companies in 2022. The SEG Index, a collection of 116 public SaaS companies, fell by 48.2%. Following are some highlights of SaaS M&A deal activity over 2022. 4Q22’s multiple of 5.6x

M&A 52
article thumbnail

Will There Be an IPO for a Specialty Consulting Company in 2024?

Focus Investment Banking

The S&P 500 has recently traded near 4800, close to its record at the end of 2021. It has taken two years to return to those levels, after 2022 and 2023 were burdened with interest rate hikes and fears of a recession. There are only a few publicly traded companies in specialty consulting. As 2024 starts, the U.S.

IPO 52